| Safeway Pharmacy #1242 | |
| 2509 E 29th Ave, Spokane, Washington 99223 | |
| (509) 532-9182 |
| Name | Safeway Pharmacy #1242 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 2509 E 29th Ave, Spokane, Washington 99223 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (509) 532-9182 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Society of Thoracic Surgeons continues to break new ground in patient safety and quality measurement through a new collaboration with the Duke Clinical Research Institute. DCRI will establish a link with STS clinical data and the Centers for Medicare & Medicaid Services claims data. This link will enable participants and researchers using data from the STS National Database to track long-term patient outcomes.
Athletes who didn't get enough sleep the night before undergoing baseline concussion testing didn't perform as well as expected, say researchers presenting their work today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Chicago, IL.
The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
› Verified 3 days ago
| NPI Number | 1043249063 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #1242 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2509 E 29th Ave, Spokane, WA 99223 |
| Phone Number | 509-532-9182 |
News Archive
The Society of Thoracic Surgeons continues to break new ground in patient safety and quality measurement through a new collaboration with the Duke Clinical Research Institute. DCRI will establish a link with STS clinical data and the Centers for Medicare & Medicaid Services claims data. This link will enable participants and researchers using data from the STS National Database to track long-term patient outcomes.
Athletes who didn't get enough sleep the night before undergoing baseline concussion testing didn't perform as well as expected, say researchers presenting their work today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Chicago, IL.
The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
› Verified 3 days ago
News Archive
The Society of Thoracic Surgeons continues to break new ground in patient safety and quality measurement through a new collaboration with the Duke Clinical Research Institute. DCRI will establish a link with STS clinical data and the Centers for Medicare & Medicaid Services claims data. This link will enable participants and researchers using data from the STS National Database to track long-term patient outcomes.
Athletes who didn't get enough sleep the night before undergoing baseline concussion testing didn't perform as well as expected, say researchers presenting their work today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Chicago, IL.
The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
› Verified 3 days ago
1st Avenue Pharmacy Type: Clinic Pharmacy Location: 6 E 1st Ave, Spokane, Washington 99202 Phone: (509) 624-3017 | |
Sav-on Pharmacy #1268 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3010 E 57th Ave, Spokane, Washington 99223 Phone: (509) 443-6502 | |
Sav-on Pharmacy #206 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9001 N Indian Trail Rd, Spokane, Washington 99208 Phone: (509) 465-8590 | |
Sav-on Pharmacy #265 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6520 N Nevada St, Spokane, Washington 99208 Phone: (509) 489-5287 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 411e North Foothills Dr 200, Spokane, Washington 99207 Phone: (509) 489-1000 |